75 related articles for article (PubMed ID: 8209595)
1. [The new nonionic contrast preparation for myelography iotrolan].
Sviridov NK
Zh Vopr Neirokhir Im N N Burdenko; 1994; (2):35-6. PubMed ID: 8209595
[No Abstract] [Full Text] [Related]
2. Comparison of nonionic contrast agents iohexol and iotrolan for cisternal myelography in dogs.
van Bree H; Van Rijssen B; Van Ham L
Am J Vet Res; 1991 Jun; 52(6):926-33. PubMed ID: 1883098
[TBL] [Abstract][Full Text] [Related]
3. The difference of contrast effects of myelography in normal dogs: comparison of iohexol (180 mgI/ml), iohexol (240 mgI/ml) and iotrolan (240 mgI/ml).
Shimizu J; Yamada K; Kishimoto M; Iwasaki T; Miyake Y
J Vet Med Sci; 2008 Jul; 70(7):659-63. PubMed ID: 18685236
[TBL] [Abstract][Full Text] [Related]
4. Renal excretion and computed tomography enhancement of iotrolan and iopamidol in dogs.
Benness G; Evill C; Wilcox J; Hassam R; Arozoo E
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():88-90. PubMed ID: 2568815
[TBL] [Abstract][Full Text] [Related]
5. [Direct cervical myelography using iotrolan 300].
Volle E; Hedde JP; Gormanns R
Rofo; 1991 Feb; 154(2):197-201. PubMed ID: 1847546
[TBL] [Abstract][Full Text] [Related]
6. [Use of iotrol for myelography].
Sviridov NK; Andreeva MN
Zh Vopr Neirokhir Im N N Burdenko; 1988; (1):50-1. PubMed ID: 3284260
[No Abstract] [Full Text] [Related]
7. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
Scholz P; Weinmann HJ; Mützel W; Staks T
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
[TBL] [Abstract][Full Text] [Related]
8. Intracranial iotrolan distribution following cervical myelography. Postmyelographic registration of adverse effects, psychometric assessment and electroencephalographic recording.
Fiirgaard B; Madsen HH; Svare U; Eriksen FB; Skjødt T; Zeeberg I
Acta Radiol; 1995 Jan; 36(1):77-81. PubMed ID: 7833174
[TBL] [Abstract][Full Text] [Related]
9. Plasma level and renal excretion of iotrolan after lumbar injection in patients.
Weinmann HJ; Vogelsang H; Mützel W; Speck U
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():224-7. PubMed ID: 2568801
[TBL] [Abstract][Full Text] [Related]
10. [Comments on the article by B. Maier et al. Iotrolan versus Iopamidol. A controlled double-blind study in lumbar myelography].
Maier B
Radiologe; 1993 Jan; 33(1):59. PubMed ID: 8441809
[No Abstract] [Full Text] [Related]
11. Tissue distribution and excretion of iotrolan after intravenous and suboccipital injections in animals.
Weinmann HJ; Scholz P; Mützel W
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():206-10. PubMed ID: 2568796
[TBL] [Abstract][Full Text] [Related]
12. Animal experimental myelography in the pig. A comparison between iohexol and iotrolan.
Skalpe IO; Tang GJ
Invest Radiol; 1995 Apr; 30(4):239-43. PubMed ID: 7635674
[TBL] [Abstract][Full Text] [Related]
13. [Hysterosalpingography using iotrolan--a new contrast medium].
Jensen HJ; Dons-Jensen H; Kamal KM
Aktuelle Radiol; 1993 Sep; 3(5):292-4. PubMed ID: 8399416
[TBL] [Abstract][Full Text] [Related]
14. [Intracranial distribution of iohexol and iotrolan after cervical myelography].
Fiirgaard B; Madsen HH; Svare U; Skjødt T; Zeeberg I
Ugeskr Laeger; 1995 Jul; 157(27):3901-4. PubMed ID: 7645065
[TBL] [Abstract][Full Text] [Related]
15. ICJ 3393: a new lodinated nonionic low osmolal dimer with low viscosity as contrast agent for X-ray.
Riefke B; González L; Carretero J; González C; Jimenéz I; Alguacil LF; Böhle F; Martin F; Martin JL
Acad Radiol; 2002 May; 9 Suppl 1():S178-81. PubMed ID: 12019862
[No Abstract] [Full Text] [Related]
16. Acute hydrocephalus after iotrolan lumbar myelography.
Tseng SH; Tseng WS
Neuroradiology; 1997 Dec; 39(12):863-4. PubMed ID: 9457711
[TBL] [Abstract][Full Text] [Related]
17. Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol.
Miyamoto Y; Tsujimoto T; Iwai K; Ishida K; Uchimoto R; Miyazawa T; Azuma H
Invest Radiol; 1995 Sep; 30(9):538-43. PubMed ID: 8537211
[TBL] [Abstract][Full Text] [Related]
18. Aseptic meningitis complicating iotrolan myelography.
Nakakoshi T; Moriwaka F; Tashiro K; Nakane K; Miyasaka K
AJNR Am J Neuroradiol; 1991; 12(1):173. PubMed ID: 1899506
[No Abstract] [Full Text] [Related]
19. Biodistribution and imaging characteristics of iotrolan-carrying interdigitation-fusion vesicles.
Seltzer SE; Janoff AS; Blau M; Adams DF; Minchey SR; Boni LT
Invest Radiol; 1991 Nov; 26 Suppl 1():S169-71; discussion S175-6. PubMed ID: 1808119
[No Abstract] [Full Text] [Related]
20. Properties and applications of a new type of iodinated gradient medium.
Bendixen B; Rickwood D
J Biochem Biophys Methods; 1994 Jan; 28(1):43-52. PubMed ID: 8151069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
